Little Cigar and Cigarillo Warnings to Reduce Tobacco-Related Cancers and Disease - Eye Tracking
NCT ID: NCT06546618
Last Updated: 2025-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2024-08-14
2025-03-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Little Cigar and Cigarillo Warnings Among US Adults Who Use LCCs
NCT05849051
Little Cigar and Cigarillo Warnings for Youth
NCT06413797
FDA Cigarette Warning Labels: Eye Tracking Study
NCT04936724
C-FLASH (Cigarillo Flavor and Abuse Liability, Attention, and Substitution in youtH)
NCT04358705
Addictive Potential of LCCs in Dual Users
NCT03496077
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In May 2016, the Food and Drug Administration (FDA) required text-only warnings on LCC packs, rotating among six statements. Research on cigarettes suggests warnings on packs should have multiple rotating sets, contain images illustrating the negative health effects associated with LCC use, and be large. However, the evidence for cigarette warning labels cannot adequately inform implementation of improved LCC warnings for four reasons: 1) The currently mandated cigar warnings differ from existing cigarette warnings; 2) there is no evidence on the effectiveness of the currently mandated cigar warnings (i.e., behavioral intentions or outcomes) or evidence on efforts that might improve LCC warnings (i.e., images, larger warning size, removal of LCC flavor descriptors on packaging); 3) Courts have ruled that one type of effective tobacco warning (i.e., for cigarettes) cannot be used to justify other types of tobacco warnings, such as those for LCCs and 4) LCC users have different demographic and consumption profiles than cigarette users (i.e., LCC users include a higher proportion of young adults African Americans, and LCCs are used on fewer days per month, which should be taken into account when developing improved warnings.
Gaps exist in understanding how LCC policies, such as the removal of flavor descriptors on packaging, influence the impact of LCC warnings. This eye tracking and psychophysiology project will provide new data to fill these evidence gaps and advance general scientific knowledge about elements of tobacco warnings research.
During the study, Participants will see 12 LCC pack stimuli images presented in random order. 3 packs will feature pictorial LCC warnings and a "Sweet" flavor descriptor, and the same 3 warnings will be presented on packs without a flavor. The remaining 6 LCC packs will have 3 text-only warnings, with 3 images containing the "Sweet" flavor and 3 images without a flavor. We will measure attention to the warnings and attention to the flavor descriptors as well as electrodermal activity and affective responses for each of the 12 stimuli.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LCC Package with pictorial warning and no flavor
Participants will see a mock LCC package with pictorial warnings and no flavor descriptor.
pictorial warning and no flavor
LCC Package with pictorial warning and no flavor
LCC Package with pictorial warning and 'sweet' flavor
Participants will see a mock LCC package with pictorial warnings and a 'sweet' flavor descriptor.
pictorial warning and 'sweet' flavor
LCC Package with pictorial warning and 'sweet' flavor
LCC Package with text-only warning and no flavor
Participants will see a mock LCC package with text-only warnings and no flavor descriptor.
text-only warning and no flavor
LCC Package with text-only warning and no flavor
LCC Package with text-only warning and 'sweet' flavor
Participants will see a mock LCC package with text-only warnings and a 'sweet' flavor descriptor
text-only warning and 'sweet' flavor
LCC Package with text-only warning and 'sweet' flavor
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pictorial warning and no flavor
LCC Package with pictorial warning and no flavor
pictorial warning and 'sweet' flavor
LCC Package with pictorial warning and 'sweet' flavor
text-only warning and no flavor
LCC Package with text-only warning and no flavor
text-only warning and 'sweet' flavor
LCC Package with text-only warning and 'sweet' flavor
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pass quality/bot screening (will answer honestly, captcha, simple math question)
* Speak English
* Current every day or some day users of LCC products
* Able to come to an appointment in NC triangle area
* Do not have any eye conditions that prevent them from being eye tracked (e.g., glaucoma, lazy eye, bifocals)
Exclusion Criteria
* Do not speak English
* Unable to pass quality/bot screening
* Unable to come to an appointment
* Eye conditions that prevent eye tracking (e.g., glaucoma, lazy eye, bifocals)
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Food and Drug Administration (FDA)
FED
UNC Lineberger Comprehensive Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adam O Goldstein
Role: PRINCIPAL_INVESTIGATOR
UNC Lineberger Comprehensive Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
University of North Carolina Lineberger Comprehensive Cancer Center Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24-0841
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.